Doro Mind

We're excited to share that Doro Mind has been awarded a grant from The National Institutes of Health (NIH) to build a digital platform addressing the relationship between substance use and serious mental illness. The research is clear: substance use, even non-disordered use, can trigger and worsen conditions like schizophrenia and bipolar disorder. Yet behavioral health has largely treated these as separate problems handled in separate systems. We're building something that addresses both, together. We're grateful to The National Institute on Drug Abuse (NIDA) and The National Institutes of Health for their support and for recognizing the importance of this work. Read more on our blog, linked in the comments below. #SeriousMentalIllness #DualDiagnosis #SBIR #BehavioralHealth

We're excited to be growing our team at Doro Mind! this is a great opportunity for a memberships healthcare leader that shares our passion for making recovery the norm for SMI. Please help us spread the word if you know anyone in your network that could be a good fit.

We came back from #NAMICon2026 with a lot on our minds. #NAMICon is one of the largest gatherings of families, clinicians, advocates, and people with lived experience of serious mental illness in the country. The team covered a lot of ground across sessions, panels, and conversations. Here is what we are still thinking about: 1. Lived experience is the most powerful change agent in this space. Families sharing their stories are moving the needle on access and stigma faster than any research publication can. 2. Caregivers are being asked to do an enormous job without nearly enough support. Families often sense a crisis coming before it arrives, and too often they are met with "you got this" instead of real training and tools. 3. Meaningful recovery is possible, and seeing it in person is impactful. One of the most powerful moments was a mother and son sharing their journey together. For families still early in that journey, visibility matters. 4. It takes a whole team. Peer mentorship, coaching, and community support are more valuable than the field has historically recognized. We wrote a full recap on the Doro blog. We'll drop a link to read more in the comments. And if you attended, what were your takeaways? Favorite panels, speakers, moments? Let us know. #NAMI #SeriousMentalIllness #MentalHealthRecovery #DoroMind #MentalHealthCommunity

We’re #hiring and excited to be growing our CA based team members. This is an exciting position for those passionate about making an impact in SMI care.

Big News: Doro Care is now available in California. 🌉 Doro Care is our most comprehensive level of support for families affected by serious mental illness: direct psychiatric care, medication management (including clozapine), and wraparound family support from a team that specializes in SMI. We're proud to be part of California's growing community of care, working to bring hope to the families who need it most. More than 70% of Doro Care members reach meaningful, sustained recovery. We believe that should be the norm, not the exception. If you or someone you love is in California, join the waitlist at https://lnkd.in/eHvWbe2f and a Doro Guide will follow up directly. And if you know a family in California who could benefit from Doro Care, please pass this along. #DoroMind #DoroCare #SeriousMentalIllness #MeaningfulRecovery #California

The Doro Mind team is heading to Atlanta this week for #NAMICon2026. We'll be sharing a booth with TEAM DANIEL Running for Recovery from Mental Illness. If you're attending, please come find us! We'd love to meet in person. We're especially looking forward to "Clozapine: Facilitating Awareness and Access" on Thurs, 5/28, from 2:15–3:15p. The panel will be bringing together three leading experts Dr. robert Laitman, Dr. Deanna L. Kelly, PharmD, BCPP, and Dr. Robert Cotes to discuss expanding access, optimizing treatment, and the broader benefits of clozapine beyond treatment-resistant schizophrenia. And perhaps most importantly, the session will include two panelists who will share their own lived experiences with clozapine. Clozapine has one of the strongest evidence bases in serious mental illness treatment and remains dramatically underused. That gap between what the evidence supports and what families actually have access to is exactly the kind of gap that Doro Mind exists to close. Make meaningful recovery the norm. See you in Atlanta. Brady Richards Mimi Liu Patrick Menard Brittany Troupe Clare Jibb David Chang Brian Liu John Mackenzie NAMI #DoroMind #MentalHealth #Clozapine #SeriousMentalIllness #NAMICon #NAMI

On Wednesday, we hosted a live conversation with Dr. Deanna L. Kelly, PharmD, BCPP about clozapine, the most effective antipsychotic medication available for treatment-resistant schizophrenia, and why so many families who need it have never been told it exists. Thank you to everyone who joined us live and to the 72 people who submitted questions ahead of the event, the most pre-submits we have received since we began these conversations. We are especially grateful to Dr. Kelly for the clarity she brought to this topic. Key insights from the session: ⚕️ The Guideline-Recommended Treatment That Gets Called a Last Resort: Clinical guidelines from the APA and many international bodies name clozapine as the recommended first-line treatment once someone has not responded to two other antipsychotics. 💉 The Blood Test Fear That Is Bigger Than the Risk: The blood monitoring requirement that scares most families originated from a rare cluster of cases in Finland in the 1970s. The actual risk of severe neutropenia is less than 1%. Dr. Kelly compared it to the risk profile of amoxicillin. 🗣️ Advocates Move Faster Than The Research: Some of the most powerful voices closing the awareness gap are not researchers. They are the family members who got their loved one on clozapine, see its positive impact, and spread the news to their community. Whether you are navigating a treatment-resistant diagnosis for the first time or have been navigating SMI for years, this conversation is for you. You can read the full wrap-up and catch the replay on our blog: https://lnkd.in/eeui6rmX We've dropped a few links for next steps in the comments below. #SeriousMentalIllness #Schizophrenia #TreatmentResistant #Clozapine #MentalHealthAdvocacy #DoroMind

When a loved one lives with psychosis, families often face a quiet, exhausting loop: medication after medication and hope after hope with no clear answer in sight. What most people don't know is that there may be a treatment their doctor hasn't mentioned yet. Join us for an honest conversation with Deanna L. Kelly, PharmD, BCPP, one of the world's leading researchers in schizophrenia care, on clozapine: the treatment too many families have never been told about.     Together, we will cover: • What clozapine is and who it is designed to help • Why it works when other medications have not • The barriers to access and how to navigate them • How to advocate for evidence-based care for your loved one We will close with a live audience Q&A. Register and submit your questions ahead of time to help shape the conversation. Clozapine: Tip the Scales Against Psychosis. 📅 Wednesday, May 20, 2026 🕓 2:00 – 3:00 PM ET 📍 YouTube Live Register at: https://lnkd.in/ekNsHgZc #Schizophrenia #Psychosis #Clozapine #SeriousMentalIllness #CaregiverSupport #MentalHealthRecovery #DoroMind

Last week we hosted a live conversation with author Hannah Bottigheimer about the reality of the "false finish line": that taxing period after a psychiatric crisis where the hospital doors close, but the real work of recovery begins. Thank you to the 125+ people who joined us live and contributed over 70 thoughtful questions. We are especially grateful to Hannah Bottigheimer for her vulnerability in sharing her family’s journey. A big thanks to Patrick Menard for hosting the discussion and to Stephanie Greer for moderating such a high-energy chat. Key insights from the session: • The "One and Done" Trap: Hannah reflected on the mistake of viewing psychosis as a passing event rather than a journey requiring daily, GPS like recalibration. • The "Nuclear Option": How the transition to Clozapine moved the family from a "spin cycle" of crises into meaningful stability. • Reclaiming Identity: Why a caregiver’s well-being is not secondary, but a radical act of survival and "rebirth" in the face of self erasure. Whether you are in the thick of a crisis or navigating the "invisible labor" of home recovery, this conversation offers a powerful reminder that you do not have to walk this path alone. You can read the full wrap-up and catch the replay on our blog: https://lnkd.in/e47rUhcc We've also dropped a few links for next steps in the comments below, including: YouTube Replay, Connecting with Doro, and Following Hannah. Meaningful recovery is a team sport! #MentalHealth #Caregiving #Psychosis #FalseFinishLine #Recovery #DoroMind

When a mental health crisis strikes, a family's initial focus is simply surviving. It’s natural to cling to the hope that bringing a loved one home from the hospital means life will return to normal. But for many, that relief is met with a challenging new reality. This certainly rang true for author and memoirist Hannah Bottigheimer. Life changed for her family overnight when Hannah’s 14-year-old daughter, Sarah, experienced a sudden onset of psychosis. Together, we’ll unpack her journey and explore: • The False Finish Line • The Toll of Caregiving • Reclaiming Selfhood We’ll close our time together with a live audience Q&A. We would love for you to be part of this open and heartfelt discussion. 📅 Thursday, April 2, 2026  🕓 7:00 – 8:30 PM ET 📍 YouTube Live RSVP to join the conversation: https://lnkd.in/eAA-N7WJ #SeriousMentalIllness #MentalHealthRecovery #CaregiverSupport #DoroMind #FalseFinishLine #PsychosisRecovery